News Feed

A new clinical trial suggests that probiotics could provide additional mental health benefits for older adults living with depression. Researchers found that seniors who took a daily probiotic supplement alongside their prescribed antidepressant medication showed slightly greater improvements in both depression and anxiety symptoms compared to those who received a placebo. While the study was relatively small and more research is needed to confirm the findings, the results highlight the growing connection between gut health and mental well-being. Scientists believe that beneficial gut bacteria may influence mood through the gut-brain axis, opening new possibilities for supporting mental health through nutrition and microbiome-based therapies.

A large study involving more than 112,000 participants has raised concerns about the potential health effects of common food preservatives. Researchers followed participants for up to eight years and found that people who consumed the highest amounts of certain food additives were more likely to develop high blood pressure and cardiovascular diseases. The study also reported increased risks of serious conditions such as heart attacks and strokes among frequent consumers of processed foods containing these preservatives. While more research is needed to establish a direct cause-and-effect relationship, the findings highlight the importance of checking food labels and limiting highly processed foods as part of a heart-healthy lifestyle.

A remarkable ancient DNA study has pushed the history of plague much further back than previously believed. Researchers analyzing remains from hunter-gatherer cemeteries in Siberia discovered evidence that plague was already infecting and killing humans around 5,500 years ago.Surprisingly, these outbreaks occurred long before the rise of cities, large-scale farming, or the rat-associated conditions commonly linked to later plague epidemics. Scientists detected early strains of the plague bacterium in nearly 40% of the individuals examined and found signs of rapid family-based transmission. Many of the victims were children and young teenagers, suggesting devastating outbreaks within small communities.The findings provide new insights into the ancient origins of one of humanity’s most notorious infectious diseases.

Fatty liver disease, once considered a harmless condition, is now being recognized as a growing driver of liver cancer in India. Experts warn that excess fat in the liver can silently progress to inflammation, fibrosis, cirrhosis, and eventually liver cancer if left untreated.The rise in obesity, diabetes, sedentary lifestyles, unhealthy diets, and alcohol consumption has significantly increased the burden of liver disease. Alarmingly, many people remain unaware they have fatty liver because symptoms often appear only after substantial damage has occurred.Doctors emphasize that early detection, regular screening for high-risk individuals, weight management, exercise, healthy eating, and limiting alcohol intake are crucial steps to prevent irreversible liver damage and reduce the risk of liver cancer.

Scientists have developed an experimental blood test that may revolutionize dementia diagnosis by identifying multiple neurodegenerative diseases simultaneously. The test measures 15 proteins in the blood and can detect conditions such as Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia, and dementia with Lewy bodies.In a recent study, the test achieved an impressive 92.3% accuracy in determining whether a person had one or more of these conditions. Unlike current blood tests that focus mainly on Alzheimer’s, this approach provides a broader picture of brain health and disease overlap.Researchers believe the technology could enable earlier, more precise diagnoses and help doctors tailor treatments to each patient’s unique condition, potentially improving outcomes and quality of life.

A promising new study has found that a copper-based compound may help the brain remove toxic proteins linked to Alzheimer’s disease. In laboratory experiments, the treatment restored the brain’s natural waste-clearing mechanisms, significantly reducing the buildup of amyloid proteins-one of the key hallmarks of Alzheimer’s.Researchers also observed notable improvements in memory and cognitive function following treatment. An exciting aspect of this discovery is that the compound has already undergone human testing for other neurological conditions, which could potentially accelerate its path toward clinical trials for Alzheimer’s disease.While more research is needed, the findings offer hope for a new therapeutic approach aimed at slowing or even reversing the progression of this devastating disorder.

A new real-world study suggests that semaglutide—sold under brand names such as Ozempic, Wegovy, and Rybelsus—may provide an unexpected benefit beyond blood sugar control and weight loss. Researchers analyzed health records from nearly 60,000 adults with type 2 diabetes and found that those taking semaglutide experienced approximately 15% fewer bone fractures compared with people using other common weight-loss medications.What makes the finding particularly notable is that semaglutide users lost more weight, a factor that can sometimes be associated with reduced bone density. The results suggest that semaglutide may help protect bone health while supporting weight management. Further research is needed, but the study offers encouraging news for people managing type 2 diabetes and obesity.

A recent study has revealed that chronic wasting disease (CWD), a fatal neurological disease affecting deer, elk, and related animals, may spread more quietly than previously thought. Researchers found that infectious prions—the abnormal proteins responsible for the disease—can be present in some animals even when they show no visible symptoms.Although there is currently no confirmed evidence that CWD can infect humans, scientists caution that the disease’s ability to evolve and potentially adapt to new hosts deserves careful monitoring. Understanding how prion diseases spread across animal populations is essential for wildlife management and public health.The findings highlight the importance of continued surveillance and research into this unusual and challenging disease.

Growing evidence suggests that diabetes and dementia are more closely connected than previously thought. Researchers have found that problems with insulin regulation and blood sugar control can affect the brain’s ability to use energy efficiently, potentially contributing to memory loss and cognitive decline.Diabetes can also increase inflammation and damage blood vessels that supply the brain, both of which are linked to a higher risk of dementia. Interestingly, scientists are now discovering that some commonly prescribed diabetes medications may help reduce the risk of developing certain forms of dementia.These findings are providing new insights into brain health and could lead to innovative strategies for preventing cognitive decline as people age.

A new study suggests that subtle changes in how children look at faces may provide early clues about their risk of developing depression. Researchers found that children with a higher inherited risk of depression tended to focus more on sad facial expressions, while those with lower genetic risk showed reduced attention to happy faces. These differences in visual attention may reflect how the brain processes emotional information long before clinical symptoms appear. The findings offer valuable insight into the complex interaction between genetics and mental health during childhood. Scientists hope this research could eventually help identify children at greater risk of depression earlier, allowing for timely support and interventions that promote better long-term mental well-being